HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B
Running, not enrolling
Conditions studied: Hepatitis B
In brief
This is an ancillary to the NIDDK-sponsored Hepatitis B Research Network (HBRN) Study Cohort Study NCT01263587. This study will examine the balance between immune regulatory and effector responses in hepatitis B-infected participants enrolled in the HBRN study (NCT01263587).
Key facts
- Study ID
- NCT01298037
- Run by
- University of Pennsylvania
- People needed
- 201
- Starts
- 2011-02-01
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2026-01-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Providing informed consent for this ancillary study.
You may not qualify if…
- Children under 18 years of age, participants with anemia
- Hgb<10 or Hct<30, congestive heart failure or chronic lung disease requiring oxygen, active coronary artery disease with unstable angina, sepsis or renal failure, other significant medical conditions, autoimmune disease or immunosuppression.
Where it is running
- California Pacific Medical Center — San Francisco, California, United States
- University of California San Francisco Medical Center — San Francisco, California, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- University of Minnesota — Plymouth, Minnesota, United States
- Mayo Clinic Rochester — Rochester, Minnesota, United States
- University of North Carolina — Chapel Hill, North Carolina, United States
- University of Texas Southwestern — Dallas, Texas, United States
- Virginia Commonwealth University — Richmond, Virginia, United States
- Virginia Mason Medical Center — Seattle, Washington, United States
- Harborview Medical Center — Seattle, Washington, United States
- University of Toronto — Toronto, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.